Infinium Pharmachem Limited (NSE:INFINIUM)
209.50
+4.45 (2.17%)
Jul 13, 2026, 3:28 PM IST
Infinium Pharmachem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 297.81 | 348.4 | 119.11 | 59.79 | 54.51 |
Cash & Short-Term Investments | 297.81 | 348.4 | 119.11 | 59.79 | 54.51 |
Cash Growth | -14.52% | 192.49% | 99.20% | 9.69% | 340.65% |
Accounts Receivable | 314.62 | 337.47 | 204.53 | 154.32 | 153.92 |
Other Receivables | - | 44.56 | 20.96 | 31.58 | 31.2 |
Receivables | 382.99 | 382.02 | 225.48 | 185.9 | 185.11 |
Inventory | 419.19 | 632.6 | 270.08 | 231.03 | 179.11 |
Other Current Assets | - | 36.14 | 35.43 | 36.41 | 18.1 |
Total Current Assets | 1,100 | 1,399 | 650.11 | 513.13 | 436.84 |
Property, Plant & Equipment | 282.34 | 216.09 | 196.5 | 188.06 | 126.79 |
Long-Term Investments | 290.25 | 290.25 | - | - | - |
Goodwill | 33.95 | 33.95 | - | - | - |
Long-Term Deferred Tax Assets | 2.41 | 1.49 | 0.17 | 0.52 | 0.67 |
Other Long-Term Assets | 40.44 | 42.91 | 7.74 | 4.41 | 25.69 |
Total Assets | 1,749 | 1,984 | 854.53 | 706.12 | 590 |
Accounts Payable | 40.73 | 123.86 | 45.13 | 68.28 | 118.17 |
Accrued Expenses | - | 15.81 | 5.41 | 4.12 | 12.6 |
Short-Term Debt | - | 348.52 | 33.53 | 155.63 | 86.71 |
Current Portion of Long-Term Debt | 152.16 | 69.98 | 0.85 | 36.16 | 2.26 |
Current Income Taxes Payable | 36.4 | 35.72 | 36.71 | 30.91 | 19.39 |
Other Current Liabilities | 57.45 | 42.04 | 52.5 | 72.6 | 75.41 |
Total Current Liabilities | 286.74 | 635.91 | 174.13 | 367.69 | 314.54 |
Long-Term Debt | - | - | - | 100.61 | 136.24 |
Other Long-Term Liabilities | 78.07 | 99.97 | 78.06 | - | - |
Total Liabilities | 364.81 | 735.88 | 252.2 | 468.3 | 450.78 |
Common Stock | 155.83 | 155.83 | 139.16 | 50.83 | 10.17 |
Additional Paid-In Capital | - | 568.23 | 161.28 | - | 7.66 |
Retained Earnings | - | 369.33 | 287.88 | 174.85 | 112.96 |
Comprehensive Income & Other | 1,055 | 1.25 | -0.52 | -0.07 | 0.24 |
Total Common Equity | 1,210 | 1,095 | 587.79 | 225.61 | 131.02 |
Minority Interest | 174.08 | 153.33 | 14.54 | 12.21 | 8.19 |
Shareholders' Equity | 1,385 | 1,248 | 602.33 | 237.82 | 139.22 |
Total Liabilities & Equity | 1,749 | 1,984 | 854.53 | 706.12 | 590 |
Total Debt | 152.16 | 418.49 | 34.38 | 292.4 | 225.21 |
Net Cash (Debt) | 145.64 | -70.09 | 84.73 | -232.6 | -170.69 |
Net Cash Per Share | 9.35 | -4.82 | 7.95 | -22.88 | -16.79 |
Filing Date Shares Outstanding | 15.55 | 15.58 | 13.92 | 13.92 | 10.17 |
Total Common Shares Outstanding | 15.55 | 15.58 | 13.92 | 10.17 | 10.17 |
Working Capital | 813.25 | 763.26 | 475.98 | 145.44 | 122.3 |
Book Value Per Share | 77.82 | 70.25 | 42.24 | 22.19 | 12.89 |
Tangible Book Value | 1,177 | 1,061 | 587.79 | 225.61 | 131.02 |
Tangible Book Value Per Share | 75.64 | 68.07 | 42.24 | 22.19 | 12.89 |
Land | - | 7.98 | - | 7.98 | 7.98 |
Buildings | - | 71.07 | - | 51.3 | 12.84 |
Machinery | - | 197.76 | - | 149.32 | 56.52 |
Construction In Progress | - | 8.47 | 0.15 | - | 84.8 |